Current appraisal of single inhaler triple therapy in COPD

A single inhaler containing inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA)/long-acting muscarinic antagonist (LAMA) is a more convenient way of delivering triple therapy in patients with COPD. Single triple therapy has been shown to be superior at reducing exacerbations and improving q...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipworth, Brian, Kuo, Chris RuiWen, Jabbal, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167973/
https://www.ncbi.nlm.nih.gov/pubmed/30319248
http://dx.doi.org/10.2147/COPD.S177333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167973/
https://www.ncbi.nlm.nih.gov/pubmed/30319248
http://dx.doi.org/10.2147/COPD.S177333

Ejemplares similares